Literature DB >> 16339428

Support for the Human Cancer Genome Project.

Harold Varmus, Bruce Stillman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16339428     DOI： 10.1126/science.310.5754.1615b

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  5 in total

Review 1.  Next-generation sequencing-based clinical sequencing: toward precision medicine in solid tumors.

Authors:  Toshifumi Wakai; Pankaj Prasoon; Yuki Hirose; Yoshifumi Shimada; Hiroshi Ichikawa; Masayuki Nagahashi
Journal:  Int J Clin Oncol       Date:  2018-12-04       Impact factor: 3.402

2.  Multigene amplification and massively parallel sequencing for cancer mutation discovery.

Authors:  Fredrik Dahl; Johan Stenberg; Simon Fredriksson; Katrina Welch; Michael Zhang; Mats Nilsson; David Bicknell; Walter F Bodmer; Ronald W Davis; Hanlee Ji
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-17       Impact factor: 11.205

3.  Formalin-fixed paraffin-embedded sample conditions for deep next generation sequencing.

Authors:  Masayuki Nagahashi; Yoshifumi Shimada; Hiroshi Ichikawa; Satoru Nakagawa; Nobuaki Sato; Koji Kaneko; Keiichi Homma; Takashi Kawasaki; Keisuke Kodama; Stephen Lyle; Kazuaki Takabe; Toshifumi Wakai
Journal:  J Surg Res       Date:  2017-07-27       Impact factor: 2.192

4.  Beyond Field Effect: Analysis of Shrunken Centroids in Normal Esophageal Epithelia Detects Concomitant Esophageal Adenocarcinoma.

Authors:  Florin M Selaru; Suna Wang; Jing Yin; Karsten Schulmann; Yan Xu; Yuriko Mori; Alexandru V Olaru; Fumiaki Sato; James P Hamilton; John M Abraham; Paul Schneider; Bruce D Greenwald; Jan Brabender; Stephen J Meltzer
Journal:  Bioinform Biol Insights       Date:  2007

Review 5.  Next generation sequencing-based gene panel tests for the management of solid tumors.

Authors:  Masayuki Nagahashi; Yoshifumi Shimada; Hiroshi Ichikawa; Hitoshi Kameyama; Kazuaki Takabe; Shujiro Okuda; Toshifumi Wakai
Journal:  Cancer Sci       Date:  2018-11-27       Impact factor: 6.716
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.